Zhejiang Provincial People's Hospital
Clinical trials sponsored by Zhejiang Provincial People's Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug cocktail aims to tame stubborn arthritis Results expected Mar 2027 (estimated)
- Can engineered red blood cells fight cancer? new trial launches Results expected Apr 2027 (estimated)
- Herbal pills tested as possible treatment for thyroid nodules Results expected Jun 2027 (estimated)
-
Can math make thyroid hormone therapy more precise?
Disease control CompletedThis trial tests a new way to personalize the dose of levothyroxine, a thyroid hormone medication, for people who have had surgery for thyroid cancer. Using mathematical and statistical models, the approach aims to predict the best dose for each individual, potentially reducing s…
Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a 'temporal interference' electric field nudge the brain back toward awareness?
Disease control CompletedThis trial tests whether a non-invasive brain stimulation technique called temporally interfering (TI) electrical stimulation can help people with disorders of consciousness, such as a minimally conscious state or unresponsive wakefulness syndrome. Participants receive either rea…
Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Cord blood cells engineered to fight stomach and pancreatic cancers
Disease control CompletedThis early-phase study tested a new treatment using immune cells from cord blood, modified to target a protein called Claudin18.2 found on some cancer cells. Ten adults with advanced stomach or pancreatic cancer who had no other options received these cells to find the safest dos…
Phase 1 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a diabetes drug also protect the heart? new study tests liraglutide
Disease control CompletedThis study screened 316 people with type 2 diabetes who were at high risk for heart disease. Researchers tested whether adding the drug liraglutide to standard care could reduce new heart problems like heart attacks, strokes, and hospitalizations. The goal was to see if this appr…
Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC